AGM/EGMApr 26, 2026, 05:29 AM
CRVS Annual Meeting June 11, 2026; Elects Directors, Ratifies Auditor
AI Summary
Corvus Pharmaceuticals, Inc. announced its Annual Meeting of Stockholders will be held virtually on June 11, 2026, at 1:00 p.m. Pacific Time. Stockholders will vote on the election of two Class I Directors, the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026, and a non-binding advisory vote on executive officer compensation. The Board of Directors recommends voting for all proposals.
Key Highlights
- Annual Meeting of Stockholders to be held virtually on June 11, 2026, at 1:00 p.m. Pacific Time.
- Stockholders to elect two Class I Directors: Richard A. Miller, M.D. and Linda S. Grais, M.D., J.D.
- Proposal to ratify PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
- Advisory vote to approve compensation of named executive officers.
- Record Date for voting is April 16, 2026.
- Audit fees for 2025 were $947,000; for 2024 were $979,425.
- Board recommends voting FOR the election of director nominees, auditor ratification, and executive compensation.
Price Impact
More from CRVS